Sarcoma / 2009 / Article / Tab 3

Clinical Study

The Value of Surgery for Retroperitoneal Sarcoma

Table 3

Univariate analysis of prognostic factors for overall survival in 41 patients with primary retroperitoneal sarcoma.

Variable 5-year survival (%) -value

Sex0.89
Female1855
Male2348
Age0.14
55 years1676
55 years2533
Duration of symptoms0.53
6 month2552
6 months110
Unknown550
Histological subtype0.94
Liposarcoma2277
Leiomyosarcoma760
MFH433
Other80
Tumor size0.26
5 cm2100
5–10 cm4100
10–20 cm1821
20 cm1760
Tumor grade0.05
Low17100
High2427
Resection0.39
R0/R13842
R2350
Resection high-grade tumor only0.03
R0/R12274
R2244
Radiation therapy0.40
Yes1953
No2263
Chemotherapy0.57
Neo-adjuvant530
Adjuvant2
Both1
None3343

Multivariate analysis significant for grade ( ).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.